100 related articles for article (PubMed ID: 25325809)
1. Special access programs and clinical research trials--an integration long overdue.
Vernillo A
Am J Bioeth; 2014; 14(11):29-31. PubMed ID: 25325809
[No Abstract] [Full Text] [Related]
2. Data donation could power the learning health care system, including special access programs.
Wicks P; Heywood JA
Am J Bioeth; 2014; 14(11):27-9. PubMed ID: 25325808
[No Abstract] [Full Text] [Related]
3. Right answer, wrong question: special access, knowledge generation, and clinical trial legitimacy.
Lowry C
Am J Bioeth; 2014; 14(11):22-4. PubMed ID: 25325806
[No Abstract] [Full Text] [Related]
4. Special access programs warrant further critical attention: authors' response to open peer commentaries on "ethical justifications for access to unapproved medical interventions: an argument for (limited) patient obligations".
Walker MJ; Rogers WA; Entwistle V
Am J Bioeth; 2014; 14(11):W1-2. PubMed ID: 25325817
[No Abstract] [Full Text] [Related]
5. Proposal for patient obligations for access to unapproved medical interventions: both too much and not enough.
Chapman A
Am J Bioeth; 2014; 14(11):25-6. PubMed ID: 25325807
[No Abstract] [Full Text] [Related]
6. Compassion and research in compassionate use.
Magnus D
Am J Bioeth; 2014; 14(11):1-2. PubMed ID: 25325800
[No Abstract] [Full Text] [Related]
7. Access to unapproved medical interventions in cases of catastrophic illness.
Schuklenk U
Am J Bioeth; 2014; 14(11):20-2. PubMed ID: 25325805
[No Abstract] [Full Text] [Related]
8. FDA implementation of the expanded access program in the United States.
Roth-Cline M; Nelson R
Am J Bioeth; 2014; 14(11):17-9. PubMed ID: 25325803
[No Abstract] [Full Text] [Related]
9. SAPs: a different perspective.
Rabourn J; Bedlack RS
Am J Bioeth; 2014; 14(11):19-20. PubMed ID: 25325804
[No Abstract] [Full Text] [Related]
10. Compassion for each individual's own sake.
Caplan A; Bateman-House A
Am J Bioeth; 2014; 14(11):16-7. PubMed ID: 25325802
[No Abstract] [Full Text] [Related]
11. Ethical justifications for access to unapproved medical interventions: an argument for (limited) patient obligations.
Walker MJ; Rogers WA; Entwistle V
Am J Bioeth; 2014; 14(11):3-15. PubMed ID: 25325801
[TBL] [Abstract][Full Text] [Related]
12. What are our moral duties? Critical reflections on clinical equipoise and publication ethics, clinical choices, and moral theory.
Cherry MJ
J Med Philos; 2013 Dec; 38(6):581-9. PubMed ID: 24225388
[No Abstract] [Full Text] [Related]
13. Taking due care: moral obligations in dual use research.
Kuhlau F; Eriksson S; Evers K; Höglund AT
Bioethics; 2008 Nov; 22(9):477-87. PubMed ID: 18959730
[TBL] [Abstract][Full Text] [Related]
14. The moral foundations of equipoise and its role in international research.
London AJ
Am J Bioeth; 2006; 6(4):48-51; discussion W42-5. PubMed ID: 16885105
[No Abstract] [Full Text] [Related]
15. Clinical ethics versus clinical research.
Appelbaum PS; Lidz CW
Am J Bioeth; 2006; 6(4):53-5; discussion W42-5. PubMed ID: 16885107
[No Abstract] [Full Text] [Related]
16. The obligation to share data … or not to share.
Sieber JE
J Empir Res Hum Res Ethics; 2011 Sep; 6(3):1-2. PubMed ID: 21931232
[No Abstract] [Full Text] [Related]
17. Free-riding and research ethics.
Allhoff F
Am J Bioeth; 2005; 5(1):50-1; author reply W15-8. PubMed ID: 16036662
[No Abstract] [Full Text] [Related]
18. Vulnerability: a needed moral safeguard.
DeMarco JP
Am J Bioeth; 2004; 4(3):82-4; discussion W32. PubMed ID: 16192156
[No Abstract] [Full Text] [Related]
19. Does uncle Sam really want you? A response to "Rethinking research Ethics" by Rosamond Rhodes (AJOB 5:1).
Trachtman H
Am J Bioeth; 2005; 5(1):W22-3. PubMed ID: 16036645
[No Abstract] [Full Text] [Related]
20. Characterizing expanded access and compassionate use programs for experimental drugs.
Miller JE; Ross JS; Moch KI; Caplan AL
BMC Res Notes; 2017 Jul; 10(1):350. PubMed ID: 28754150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
